Published in Virchows Arch A Pathol Anat Histopathol on January 01, 1988
Penile cancer: epidemiology, pathogenesis and prevention. World J Urol (2008) 2.14
Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study. Ann Oncol (2010) 5.91
Guide to the assessment of percentage "impairment" of the back, neck and pelvis. Australasian College of Rehabilitation Medicine. Med J Aust (1992) 4.59
Randomised trial of single and repeated fibrin glue compared with injection of polidocanol in treatment of bleeding peptic ulcer. Lancet (1997) 2.09
Toward the harmonization of immune monitoring in clinical trials: quo vadis? Cancer Immunol Immunother (2007) 2.00
Clinicopathologic analysis of patients with adult rhabdomyosarcoma. Cancer (2001) 1.86
Detection of Campylobacter pyloridis in patients with antrum gastritis and peptic ulcers by culture, complement fixation test, and immunoblot. J Clin Microbiol (1986) 1.85
T cell assays and MIATA: the essential minimum for maximum impact. Immunity (2012) 1.74
From adaptive licensing to adaptive pathways: delivering a flexible life-span approach to bring new drugs to patients. Clin Pharmacol Ther (2015) 1.59
CD66a (BGP), an adhesion molecule of the carcinoembryonic antigen family, is expressed in epithelium, endothelium, and myeloid cells in a wide range of normal human tissues. J Histochem Cytochem (1996) 1.59
Analysis of oral papillomas, leukoplakias, and invasive carcinomas for human papillomavirus type related DNA. J Invest Dermatol (1985) 1.47
Overexpression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype. Breast Cancer Res Treat (2001) 1.46
Immunoblot analysis of immune response to Campylobacter pylori and its clinical associations. J Clin Pathol (1988) 1.41
Hürthle cell carcinoma: a critical histopathologic appraisal. J Clin Oncol (2001) 1.37
Performance of serum-supplemented and serum-free media in IFNgamma Elispot Assays for human T cells. Cancer Immunol Immunother (2009) 1.36
Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond. Cancer Immunol Immunother (2010) 1.36
MAGE-A gene expression pattern in primary breast cancer. Cancer Res (2001) 1.34
Soft tissue tumors of the abdominal wall: analysis of disease patterns and treatment. Arch Surg (2001) 1.29
MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours. Br J Cancer (2012) 1.28
Expression and prognostic relevance of activated extracellular-regulated kinases (ERK1/2) in breast cancer. Br J Cancer (2005) 1.22
Keratin polypeptides distribution in normal and diseased human epidermis and oral mucosa. Immunohistochemical study on unaltered epithelium and inflammatory, premalignant and malignant lesions. Virchows Arch A Pathol Anat Histol (1980) 1.18
Cell types infected in human cytomegalovirus placentitis identified by immunohistochemical double staining. Virchows Arch A Pathol Anat Histopathol (1993) 1.17
Expression pattern of the AP-1 family in breast cancer: association of fosB expression with a well-differentiated, receptor-positive tumor phenotype. Int J Cancer (1999) 1.16
Immunization with DNA coding for gp100 results in CD4 T-cell independent antitumor immunity. Surgery (2000) 1.15
Laparoscopic ultrasound enhances standard laparoscopy in the staging of pancreatic cancer. Ann Surg (1998) 1.12
Differential expression of CD66a (BGP), a cell adhesion molecule of the carcinoembryonic antigen family, in benign, premalignant, and malignant lesions of the human mammary gland. J Histochem Cytochem (1997) 1.11
In situ hybridization for the detection of cytomegalovirus (CMV) infection. Application of biotinylated CMV-DNA probes on paraffin-embedded specimens. Virchows Arch A Pathol Anat Histopathol (1986) 1.11
Matrix-metalloproteinases 1, 2, and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: an in situ hybridization study. Virchows Arch (1999) 1.09
Societal preference values for advanced melanoma health states in the United Kingdom and Australia. Br J Cancer (2009) 1.09
Human papillomavirus type 13 and focal epithelial hyperplasia of the oral mucosa: DNA hybridization on paraffin-embedded specimens. Virchows Arch A Pathol Anat Histopathol (1987) 1.09
Endoscopic ultrasound-guided, 18-gauge, fine needle aspiration biopsy of the pancreas using a 2.8 mm channel convex array echoendoscope. Gastrointest Endosc (1998) 1.08
Overexpression of TACE and TIMP3 mRNA in head and neck cancer: association with tumour development and progression. Br J Cancer (2010) 1.06
p16/MTS1 inactivation in ovarian carcinomas: high frequency of reduced protein expression associated with hyper-methylation or mutation in endometrioid and mucinous tumors. Int J Cancer (1998) 1.04
Expression of cyclin-dependent kinase inhibitors p16MTS1, p21WAF1, and p27KIP1 in HPV-positive and HPV-negative cervical adenocarcinomas. Virchows Arch (2001) 1.04
Expression pattern of the AP-1 family in endometrial cancer: correlations with cell cycle regulators. J Cancer Res Clin Oncol (2001) 0.99
Study of neu-protein expression in mammary Paget's disease with and without underlying breast carcinoma and in extramammary Paget's disease. Am J Pathol (1990) 0.99
Progesterone receptor isoforms, PR-B and PR-A, in breast cancer: correlations with clinicopathologic tumor parameters and expression of AP-1 factors. Horm Res (2000) 0.98
A simple and rapid technique to process formalin-fixed, paraffin-embedded tissues for the detection of viruses by the polymerase chain reaction. Virchows Arch A Pathol Anat Histopathol (1992) 0.96
Association of human papillomavirus infection with carcinoma of the cervix uteri and its precursor lesions: theoretical and practical implications. Virchows Arch (2000) 0.96
Dysregulated expression of CD66a (BGP, C-CAM), an adhesion molecule of the CEA family, in endometrial cancer. Am J Pathol (1998) 0.95
Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression. J Neurooncol (2001) 0.95
cis Interaction of the cell adhesion molecule CEACAM1 with integrin beta(3). Am J Pathol (2001) 0.95
Human papillomavirus DNA in oral squamous cell carcinomas and normal mucosa. J Oral Pathol Med (1994) 0.94
The MYB-NFIB gene fusion-a novel genetic link between adenoid cystic carcinoma and dermal cylindroma. J Pathol (2011) 0.94
Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression. J Neurosurg (2000) 0.93
P16/MTS1 and pRB expression in endometrial carcinomas. Virchows Arch (1999) 0.92
[Differential diagnosis of basaloid salivary gland tumors]. Pathologe (2004) 0.92
Human endogenous retrovirus (HERV)-K transcripts in germ cell and trophoblastic tumours. APMIS (1998) 0.91
Differential telomerase activity, expression of the telomerase catalytic sub-unit and telomerase-RNA in ovarian tumors. Int J Cancer (1999) 0.91
Expression of cell cycle-regulatory proteins rb, p16/MTS1, p27/KIP1, p21/WAF1, cyclin D1 and cyclin E in breast cancer: correlations with expression of activating protein-1 family members. Int J Cancer (2000) 0.91
Identification of allelic losses in benign, borderline, and invasive epithelial ovarian tumors and correlation with clinical outcome. Cancer (1997) 0.90
Differential expression of the monocyte chemoattractant protein-1 gene in human papillomavirus-16-infected squamous intraepithelial lesions and squamous cell carcinomas of the cervix uteri. Am J Pathol (1996) 0.90
Expression of cell-cycle regulatory proteins in endometrial carcinomas: correlations with hormone receptor status and clinicopathologic parameters. J Cancer Res Clin Oncol (2001) 0.89
Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva. Int J Cancer (1995) 0.89
Leukemia inhibitory factor (LIF) stimulates the human HLA-G promoter in JEG3 choriocarcinoma cells. J Clin Endocrinol Metab (2000) 0.88
Comparative investigation of c-erbB2/neu expression in head and neck tumors and mammary cancer. Cancer (1991) 0.88
Human endogenous retrovirus (HERV)-K transcripts in gonadoblastomas and gonadoblastoma-derived germ cell tumours. Virchows Arch (1999) 0.88
p53 is a persistent and predictive marker in advanced ovarian carcinomas: multivariate analysis including comparison with Ki67 immunoreactivity. J Cancer Res Clin Oncol (1997) 0.88
Human papillomavirus (HPV) infection of cervical lesions detected by immunohistochemistry and in situ hybridization. Cancer Detect Prev (1986) 0.88
Impact of cytokeratin-20 and carcinoembryonic antigen mRNA detection by RT-PCR in regional lymph nodes of patients with colorectal cancer. Br J Cancer (2000) 0.87
[Significance of molecular-cytogenetic findings in mucoepidermoid carcinoma as an example of salivary gland tumors]. Pathologe (2005) 0.87
Identification of Langerhans cells: simultaneous use of sera to intermediate filaments, T6 and HLA-DR antigens on oral mucosa, human epidermis and their tumours. Virchows Arch A Pathol Anat Histopathol (1982) 0.87
Translocations t(11;18)(q21;q21) and t(14;18)(q32;q21) are the main chromosomal abnormalities involving MLT/MALT1 in MALT lymphomas. Leukemia (2003) 0.87
Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence. Eur Urol (2001) 0.87
Relaxin-like factor (RLF): a new specific marker for Leydig cells in the ovary. Int J Gynecol Pathol (1999) 0.86
Deregulated expression of p16INK4a and p53 pathway members in benign and malignant myoepithelial tumours of the salivary glands. Histopathology (2008) 0.86
Human papillomavirus detection in cervical adenocarcinoma by polymerase chain reaction. Hum Pathol (1993) 0.85
PTEN expression in breast and endometrial cancer: correlations with steroid hormone receptor status. Pathobiology (2001) 0.85
The adhesion molecule CEACAM1 (CD66a, C-CAM, BGP) is specifically expressed by the extravillous intermediate trophoblast. Am J Pathol (2000) 0.85
Breast cancer metastatic to the uterine cervix: analysis of a rare event. Cancer Invest (1999) 0.85
Glutamine enhances gut glutathione production. JPEN J Parenter Enteral Nutr (1998) 0.85
Thymolipoma in association with myasthenia gravis. Cancer (1982) 0.85
In situ detection of human papillomavirus types 13 and 32 in focal epithelial hyperplasia of the oral mucosa. J Oral Pathol Med (1989) 0.85
Immunomorphological and ultrastructural aspects of keratinocyte migration in epidermal wound healing. Virchows Arch A Pathol Anat Histol (1981) 0.84
Prognostic significance of Leu-M1 immunostaining in papillary carcinomas of the thyroid gland. Virchows Arch A Pathol Anat Histopathol (1987) 0.84
Differences in HPV 16- and HPV 18 E6/E7 oncogene expression between in situ and invasive adenocarcinomas of the cervix uteri. Virchows Arch (2000) 0.84
[Phenotype-genotype correlations in salivary gland tumors. Status of molecular analysis]. Laryngorhinootologie (2001) 0.84
Expression patterns of the cell-cycle inhibitor p27 and the cell-cycle promoter cyclin E in the human placenta throughout gestation: implications for the control of proliferation. Placenta (1999) 0.83
[Detection of human papillomavirus (HVP)-DNA in oral manifestation of lichen planus]. Mund Kiefer Gesichtschir (1997) 0.83
Expression of c-erbB2 and c-myc in squamous epithelia and squamous cell carcinomas of the head and neck and the lower female genital tract. J Oral Pathol Med (1990) 0.83
Expression of Rb2/p130 in breast and endometrial cancer: correlations with hormone receptor status. Br J Cancer (2001) 0.83
Dendritic/Langerhans cells and prognosis in patients with papillary thyroid carcinomas. Immunocytochemical study of 106 thyroid neoplasms correlated to follow-up data. Am J Clin Pathol (1988) 0.83
Strongly reduced expression of the cell cycle inhibitor p27 in endometrial neoplasia. Virchows Arch (1999) 0.82
The glucocorticoid receptor is specifically expressed in the stromal compartment of the human endometrium. J Clin Endocrinol Metab (2001) 0.82
Relationship between telomerase activation and HPV 16/18 oncogene expression in squamous intraepithelial lesions and squamous cell carcinomas of the uterine cervix. Int J Gynecol Pathol (2001) 0.82
[About the prognostic value of Her-2 gene-amplification and cell-proliferation in salivary duct carcinoma of the major salivary glands - a pilot-study]. Laryngorhinootologie (2001) 0.81
Osteosarcomas and Ewing's sarcomas. Comparative immunocytochemical investigation of filamentous proteins and cell membrane determinants. Virchows Arch A Pathol Anat Histopathol (1985) 0.81
Keratin and tissue polypeptide antigen profiles of the cervical mucosa. Int J Gynecol Pathol (1983) 0.81
Histological and immunocytochemical examinations of the stromal reaction in carcinomas of the parotid gland. Analysis of 52 cases. J Cancer Res Clin Oncol (1980) 0.81
Occurrence of papillomavirus structural antigens in oral papillomas and leukoplakias. J Oral Pathol (1984) 0.81
Molecular and immunohistochemical analysis of p53 mutations in scrapings and tissue from preinvasive and invasive breast cancer. Virchows Arch (1997) 0.81
Tissue polypeptide antigen and keratins in cervical neoplasia. Int J Gynecol Pathol (1986) 0.80
Immunocytochemical demonstration of filamentous structures in the parotid gland. Occurrence of keratin and actin in normal and tumoral parotid gland with special respect to the myoepithelial cells. J Cancer Res Clin Oncol (1981) 0.80
[Immunohistochemical characterization of salivary gland tumors with tissue micro-arrays]. Pathologe (2005) 0.80
HPV DNA and p53 alterations in oropharyngeal carcinomas. Virchows Arch (1995) 0.80
Epidermal Langerhans' cell densities influence survival in mycosis fungoides and Sézary syndrome. Cancer (1990) 0.80
p53 tumour suppressor gene mutations in benign prostatic hyperplasia and prostate cancer. Eur Urol (1998) 0.80
p53 mutations in ovarian tumors, detected by temperature-gradient gel electrophoresis, direct sequencing and immunohistochemistry. Int J Cancer (1995) 0.79
Expression and tissue localization of soluble guanylyl cyclase in the human placenta using novel antibodies directed against the alpha(2) subunit. J Clin Endocrinol Metab (2001) 0.79
[Diagnostic mammography and sonography: concordance of the breast imaging reporting assessments and final clinical outcome]. Rofo (2005) 0.79
Herpes virus infections, acute rejection, and transplant arteriosclerosis in human cardiac allografts. Transplant Proc (1993) 0.79